Laura Marmolejo

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Human IgLON5 Antibodies Reduce Neuronal IgLON5 Clusters and Cause Motor Dysfunction in Mice.

Human IgLON5 Antibodies Reduce Neuronal IgLON5 Clusters and Cause Motor Dysfunction in Mice.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: May 19, 2026

Reply to "Demographic Confounding and Model Robustness in the Prognostic Evaluation of NMDAR Encephalitis Glycoprofiles".

Reply to "Demographic Confounding and Model Robustness in the Prognostic Evaluation of NMDAR Encephalitis Glycoprofiles".

Journal: Annals of neurology

Published: April 28, 2026

Antibody-Mediated Mechanisms in Autoimmune Neurological Disorders.

Antibody-Mediated Mechanisms in Autoimmune Neurological Disorders.

Journal: The European journal of neuroscience

Published: February 24, 2026

Relapses, Comorbidities, and Predictors of Outcome in Anti-GABAA Receptor Encephalitis.

Relapses, Comorbidities, and Predictors of Outcome in Anti-GABAA Receptor Encephalitis.

Journal: Annals of neurology

Published: December 18, 2025

Complications, outcomes, and implications of a prolonged vegetative state in anti-NMDA receptor encephalitis: a retrospective international cohort study.

Complications, outcomes, and implications of a prolonged vegetative state in anti-NMDA receptor encephalitis: a retrospective international cohort study.

Journal: The Lancet. Neurology

Published: October 17, 2025

CSF-Compartmentalized Antibody Glycoprofiles in NMDAR Encephalitis Associate with Etiology and Functional Recovery.

CSF-Compartmentalized Antibody Glycoprofiles in NMDAR Encephalitis Associate with Etiology and Functional Recovery.

Journal: Annals of neurology

Published: October 06, 2025

Clinical Characterization and Long-Term Outcome in Children and Adults With Anti-AMPA Receptor Encephalitis.

Clinical Characterization and Long-Term Outcome in Children and Adults With Anti-AMPA Receptor Encephalitis.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: July 18, 2025

Assessing Commercial Tissue-Based Assays for Autoimmune Neurologic Disorders (I): Antibodies to Intracellular Antigens.

Assessing Commercial Tissue-Based Assays for Autoimmune Neurologic Disorders (I): Antibodies to Intracellular Antigens.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: May 20, 2025

Assessing Commercial Tissue-Based Assays for Autoimmune Neurologic Disorders (II): Antibodies to Surface Antigens.

Assessing Commercial Tissue-Based Assays for Autoimmune Neurologic Disorders (II): Antibodies to Surface Antigens.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: May 20, 2025

Neuro-immunobiology and treatment assessment in a mouse model of anti-NMDAR encephalitis.

Neuro-immunobiology and treatment assessment in a mouse model of anti-NMDAR encephalitis.

Journal: Brain : a journal of neurology

Published: June 17, 2024

Humoral signatures of Caspr2-antibody spectrum disorder track with clinical phenotypes and outcomes.

Humoral signatures of Caspr2-antibody spectrum disorder track with clinical phenotypes and outcomes.

Journal: Med (New York, N.Y.)

Published: June 13, 2024

Positive Allosteric Modulation of NMDARs Prevents the Altered Surface Dynamics Caused by Patients' Antibodies.

Positive Allosteric Modulation of NMDARs Prevents the Altered Surface Dynamics Caused by Patients' Antibodies.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: May 21, 2024

Showing 1-12 of 12

Last Updated: 09/26/2026